RxDoctor Payments Data

Gary Keepes, MD

Family Medicine · Petersburg, INNPI 1104829480

Payments from drug & device makers

$478in general payments, 2019–2025

Across 36 payments — averaging $13.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$63
  • Lilly USA, LLC$56
  • AbbVie$55
  • Takeda Pharmaceuticals U.S.A., Inc.$42
  • Mylan Specialty L.p.$38
  • Amgen$35
  • plus $187 from 11 others

What the payments were for

  • Food & beverage$478100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$478 in reported general payments places this provider in the 45th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$1,779
Medicare patients
19
Services billed
20

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin390$242,885
EliquisApixaban277$185,348
OzempicSemaglutide165$176,724
Trelegy ElliptaFluticasone/Umeclidin/Vilanter114$87,743
JanuviaSitagliptin Phosphate97$63,363
XareltoRivaroxaban71$50,228
LinzessLinaclotide81$46,555
MyrbetriqMirabegron96$40,821
Tresiba Flextouch U-100Insulin Degludec58$38,601
EntrestoSacubitril/Valsartan66$31,660
MounjaroTirzepatide24$28,243
RexultiBrexpiprazole24$24,613
FarxigaDapagliflozin Propanediol26$20,488
VraylarCariprazine Hcl23$19,457
Repatha PushtronexEvolocumab21$18,144

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$11$250,915418 claims
PfizerEliquis$12$185,348277 claims
Novo NordiskOzempic$63$176,724165 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$32$112,791164 claims
AbbVieLinzess, Vraylar, Restasis, Synthroid$55$81,537185 claims
Johnson & JohnsonXarelto$13$50,22871 claims
NovartisEntresto$11$31,66066 claims
AstraZenecaFarxiga, Breztri Aerosphere$28$29,21838 claims
Lilly USA, LLCMounjaro$56$28,24324 claims
Otsuka America Pharmaceutical, Inc.Rexulti$28$24,61324 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Petersburg

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →